-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $2

Benzinga·05/09/2025 11:10:21
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and lowers the price target from $5 to $2.